Search

everythinglearnresearchcommunity

for

Search:↓

Rapamycin treatment helps reduce brain inflammation and symptoms of mitochondrial disease by blocking specific pathways in mice.

Baricitinib, a medication taken by mouth, was effective in regrowing hair for people with severe hair loss.

Baricitinib works better in adolescents than adults for treating severe alopecia areata.

Systemic immunotherapies are used for immune-related hair loss but not usually for genetic hair loss, unless the patient has both conditions.

Suppressing ODC activity reduces tumor growth in hair follicles.

Ritlecitinib effectively promotes hair regrowth in severe and very severe alopecia areata.

Mice without the IL-6 gene had more hair growth after injury due to higher activity of a related protein, Stat3.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

Axitinib treatment turned a man's grey hair back to black.

Chronic refractory alopecia areata has more skin-resident memory T cells, and JAK inhibitors may help reduce them.

A medicine called tofacitinib worked to treat a hair loss condition linked with a muscle and skin disease.

Promising cancer treatments were found, but the manufacturer closed.

Renal transplant patients on tacrolimus and sirolimus may develop acne keloidalis nuchae.

Blocking certain immune signals can reduce skin damage from radiation therapy.

Deucravacitinib did not significantly improve hair regrowth in alopecia areata patients.

Checkpoint inhibitor therapy can cause skin issues, from mild rashes to severe reactions.

Baricitinib significantly improved hair regrowth and skin condition in a 14-year-old with alopecia areata and atopic dermatitis.

Blocking Oncostatin M's role in the JAK-STAT pathway can stimulate hair growth in mice.

Small molecules KY19382 and KY19334 may help treat skin cancer by reducing CDK1 levels and blocking harmful cell signals.

Tofacitinib can help hair grow back in alopecia patients but hair loss might return if the dose is lowered.

Rapamycin treatment helps with mitochondrial disease by reducing PKC levels.

CD8+ T cells are involved in alopecia areata and may cause disease relapse.

Ritlecitinib effectively regrows hair in adolescents with alopecia areata and is safe.

NKIRAS2 can suppress certain skin tumors but its effect on cancer varies with context and expression level.

IL-1 alpha stops hair follicle growth and hair production.

Tofacitinib works well for treating alopecia areata, especially when combined with corticosteroids, but is less effective if the disease has lasted over 2 years.

Juniperus communis extract enhances the effectiveness of oral cancer treatment when combined with chemotherapy.

The research developed methods to test drugs that could protect and restore hair follicle protection in a hair loss condition.

Compounds from Pterocarpus indicus may help treat benign prostatic hyperplasia by stopping cell growth.